Justin has over 25 years of experience in the medical device industry. As an operator, Justin has spent time in both a large strategic as well as in start-up focusing on research and development as well as clinical, regulatory, quality, marketing and manufacturing. In 2018, Justin became an investor as a founding Partner at Revival Healthcare Capital. Prior to Revival, Justin was the Chief Operating Officer at Cardiva Medical which was acquired by Haemonetics for $510MM. While at Cardiva, Justin led the approval of two PMA-track vascular closure devices and completed several multi-center, prospective clinical trials focused on clinical efficacy and economic value. Justin led the building of an offshore manufacturing facility that was recipient of the Shingo Award for manufacturing and operational excellence in 2018.Prior to Cardiva, Justin spent 12 years at J&J with increasing senior leadership roles ultimately leading to responsibility for new business assessments and strategic marketing for next generation structural heart and drug-eluting stents. While in research and development at J&J, Justin was responsible for global new product development and commercialization in both the US and the EU for the cardiovascular technoloiges business unit. Justin currently serves as a Director on the Board for Kardion and a Board Observer at Distalmotion S.A. and holds a B.S. in Biomedical & Mechanical Engineering from the University of Miami, an M.S. in Engineering Management from Florida International University and an MBA from Columbia Business School and Hass School of Business.